Genrix Bio 智翔金泰
2 significant filings since 29 May 2026: 2 on new listing. The latest, on 16 Jun 2026: 首次公开发行部分限售股上市流通公告. 1 unverified report logged, the latest on 21 Sep 2026.
自 29 May 2026 起有 2 份重大公告：new listing 2 份。最新一份（16 Jun 2026）：首次公开发行部分限售股上市流通公告。记录了 1 条未经核实的报道，最新一条见于 21 Sep 2026。
| FY2026 | FY2027 | |
|---|---|---|
| Now 当前 | 1 broker | 1 broker |
| 7 days ago | 1 broker | 1 broker |
| 30 days ago | 1 broker | 1 broker |
| 60 days ago | 1 broker | 1 broker |
| 90 days ago | 1 broker | 1 broker |
Consensus is the median of each broker's latest forecast from the 120 days before each date. With fewer than 3 brokers, the broker count is shown. 一致预期为各券商在该日期前 120 天内最新预测的中位数；不足 3 家时显示券商数。
Consensus moved from -1.26 in Sep 2024 to -0.95 in Dec 2025 (+24.6%). 一致预期从 Sep 2024 的 -1.26 变为 Dec 2025 的 -0.95 (+24.6%)。 The shaded band runs from the lowest to the highest broker forecast.
| FY2026 | FY2027 | |
|---|---|---|
| Last 30 days | ▲ 1 ▼ 0 = 0 | ▲ 1 ▼ 0 = 0 |
| Last 90 days | ▲ 1 ▼ 0 = 0 | ▲ 1 ▼ 0 = 0 |
Each broker's latest forecast is compared with its previous forecast for the same year. A move within 0.5% counts as unchanged. 每家券商的最新预测与其对同一年度的上一次预测比较，变动在 0.5% 以内视为不变。
| Year | Filed | Consensus | Brokers 券商 | Reported 实际 | Surprise 偏差 |
|---|---|---|---|---|---|
| FY2023 | 30 Apr 2024 | -2.19 | 3 | -2.50 | -14.2% |
Surprise is reported EPS against the consensus on the day before the annual report was filed. 偏差为实际每股收益与年报披露前一日一致预期之差。
A surprise needs at least 3 brokers forecasting in the 120 days before the filing. FY2025 had 0 and FY2024 had 0.